Immunophage Biotech Funding: $29M Raised, Series B (2023)
Immunophage Biotech is based in Shanghai, China. It has raised $29M in total funding. Latest round: Series B. Backed by ZBJL CAPITAL.
Immunophage Biotech funding overview
Immunophage Biotech is based in Shanghai, China. Immunophage Biotech has raised $29M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in March 2023. The round record for Immunophage Biotech runs through 2023; nothing later has been disclosed. Investors on record include ZBJL CAPITAL.
Immunophage Biotech at a glance
Total raised
$29M
Latest round
Series B
Latest round date
March 2023
Headquarters
Shanghai, China
Notable investors
ZBJL CAPITAL
Frequently asked about Immunophage Biotech funding
How much has Immunophage Biotech raised?
Immunophage Biotech has raised $29M in total disclosed funding across the rounds on record.
Who has invested in Immunophage Biotech?
ZBJL CAPITAL are named among the investors backing Immunophage Biotech.
What was the latest Immunophage Biotech funding round?
The most recent disclosed round is a Series B, announced in March 2023.
Where is Immunophage Biotech based?
Immunophage Biotech is based in Shanghai, China.
When did Immunophage Biotech last raise?
The last disclosed Immunophage Biotech round closed in March 2023 at Series B.
We update the Immunophage Biotech record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Shanghai and their backers are listed below.
